They are more often treated with antiarrhythmic drugs, which, together with an increased risk of thrombosis, their postmenopausal status, and obesity, might indicate their worse cardiovascular condition, reflected in increased parameters of endothelial function, sICAM-1, and soluble TM (Table 1). The gene discussed is THBD; the disease is obesity due to melanocortin 4 receptor deficiency.